By Adria Calatayud Germany's Merck KGaA is scheduled to report results for the third quarter on Thursday. Here is what you need to know: SALES FORECAST: The.
By Adria Calatayud Germany's Merck KGaA has entered into a partnership to license a cancer drug developed by China's Jiangsu Hengrui Pharmaceuticals for up.
By Adria Calatayud Shares of Germany's Merck KGaA rose after the company forecast a return to organic sales growth next year, supported by recovering demand.
Health-care companies fell, but not by as much as the broad market, as traders rotated into defensive sectors. Pfizer shares declined after the Big Pharma.